Thomas Lennart Eklund

Thomas Lennart Eklund

Direttore/Membro del Consiglio presso SURGICAL SCIENCE SWEDEN AB

Patrimonio netto: 14 M $ in data 31/05/2024

57 anni
Health Technology
Finance
Commercial Services

Profilo

Thomas Lennart Eklund is currently the Chief Executive Officer & Director at Tedsalus AB.
He is also serving as the Chairman at Immedica Pharma AB, Sedana Medical AG, Mabtech AB, Itrim Sverige AB, Swevet Piab AB, Circassia AB, Mabtech Holding AB, Mabtech Group Holding AB, Surgical Science Sweden AB, Boule Diagnostics AB, Memira Holding AB, Rodebjer Form AB, Tedcap AB, Swedencare AB, Alfred Berg ABN AMRO Capital Investment AB, GHP International AB, Bariatric & Diabetes Center Ajman AB, Excillum AB, Bio-Works Sweden AB, Impilo.
No 4 Holding Ii AB, Bioworks AB, Immedica Pharma Holding AB, Swedencare AB (publ), ADDvise Group AB (starting in 2024), and Impilo AB (as an Industrial Partner since 2017).
In the past, Mr. Eklund served as the Chairman of Keybroker AB, Moberg Pharma AB (from 2016 to 2019), GHP Specialty Care AB (from 2014 to 2016), and Immedica Pharma AB (in 2020).
He was also the Chairman of BoMill AB, Itrim Holding AB, Bomill Holding AB, Swevet Holding AB, and Sedana Medical AB.
Additionally, he held the position of Director at Aerocrine AB (from 2011 to 2012), Biotage AB (from 2006 to 2007), Affibody Medical AB, Investor Growth Capital AB (from 2002 to 2014), Swedish Orphan International Holding AB (from 2004 to 2010), Carmel Pharma AB, SciBase Holding AB (from 2017 to 2019), Newron Sweden AB (as Deputy Director), Neoventa Medical AB, Calliditas Therapeutics AB (from 2019 to 2020), Tobii AB, Memira AB, Dipylon Medical AB, Peseq AB, PocketMobile Communications AB, Vårdapoteket i Norden AB (in 2012), Neoventa Holding AB, Scibase Intressenter AB, Observe Medical International AB, Bio-Works Technologies AB, and SciBase AB.
Mr. Eklund obtained an MBA from the Stockholm School of Economics.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
31/12/2023 953 582 ( 0.60% ) 5 M $ 31/05/2024
31/12/2023 1 666 464 ( 1.68% ) 4 M $ 31/05/2024
31/03/2024 4 038 728 ( 10.40% ) 4 M $ 31/05/2024
31/05/2024 299 344 ( 0.21% ) 250 467 $ 31/05/2024
31/05/2024 61 402 ( 14.49% ) 61 301 $ 31/05/2024
31/12/2022 1 000 ( 0.00% ) 13 749 $ 31/05/2024

Posizioni attive di Thomas Lennart Eklund

SocietàPosizioneInizio
SWEDENCARE AB Direttore/Membro del Consiglio 01/01/2016
BOULE DIAGNOSTICS AB Direttore/Membro del Consiglio 01/01/2014
SURGICAL SCIENCE SWEDEN AB Direttore/Membro del Consiglio 01/01/2017
ADDVISE GROUP AB Direttore/Membro del Consiglio 03/05/2024
Amministratore Delegato -
Direttore/Membro del Consiglio -
Presidente -
Investitore di Private Equity 01/01/2017
Impilo No 4 Holding Ii AB Direttore/Membro del Consiglio -
░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
░░░░░░░░ ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ -
Tutte le posizioni attive di Thomas Lennart Eklund

Precedenti posizioni note di Thomas Lennart Eklund

SocietàPosizioneFine
░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░ ░░ ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░░ ░░░░ ░░ ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Thomas Lennart Eklund

Formazione di Thomas Lennart Eklund

Stockholm School of Economics Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas Lennart Eklund

Relazioni

100 +

Relazioni di 1° grado

57

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa12
BIOTAGE AB

Health Technology

ADDVISE GROUP AB

Distribution Services

SCIBASE HOLDING AB (PUBL)

Health Technology

CALLIDITAS THERAPEUTICS AB

Health Technology

SURGICAL SCIENCE SWEDEN AB

Health Technology

BOULE DIAGNOSTICS AB

Health Technology

TOBII AB

Electronic Technology

MOBERG PHARMA AB

Health Technology

BOMILL AB

Technology Services

SWEDENCARE AB

Health Technology

BIO-WORKS TECHNOLOGIES AB

Health Technology

SEDANA MEDICAL AB

Health Technology

Aziende private44

Electronic Technology

Health Technology

Finance

Finance

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Services

Commercial Services

Technology Services

Retail Trade

Rodebjer Form AB

Miscellaneous

Scibase Intressenter AB

Health Technology

Sedana Medical AG

Tedcap AB

Commercial Services

Consumer Services

Health Technology

Scibase AB

Bomill Holding AB

Alfred Berg ABN AMRO Capital Investment AB

Swevet Piab AB

Commercial Services

Finance

Bariatric & Diabetes Center Ajman AB

Finance

Commercial Services

Health Technology

Health Technology

Health Technology

Impilo No 4 Holding Ii AB

Bioworks AB

Immedica Pharma Holding AB

Finance

Mabtech Group Holding AB

Process Industries

Technology Services

Health Services

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Thomas Lennart Eklund